Orgenesis Inc. Common Stock
ORGS
ORGS was delisted on the 18th of October, 2024.
20 hedge funds and large institutions have $980K invested in Orgenesis Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 4 closing their positions.
2.2% less ownership
Funds ownership: 7.73% → 5.52% (-2.2%)
9% less funds holding
Funds holding: 22 → 20 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
68% less capital invested
Capital invested by funds: $3.04M → $980K (-$2.06M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$29.1K |
| 2 |
Prudential Financial
Newark,
New Jersey
|
+$17K |
| 3 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$16.4K |
| 4 |
JP Morgan Chase
New York
|
+$27 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RAM
Redmond Asset Management
Henrico,
Virginia
|
-$806K |
| 2 |
Walleye Capital
New York
|
-$38.7K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$23K |
| 4 |
FIM
Freedom Investment Management
Hartford,
Connecticut
|
-$17.4K |
| 5 |
BlackRock
New York
|
-$13.2K |
ORGS Hedge Fund Activity: Q3 2023 in Review
20 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Orgenesis Inc. Common Stock (ORGS) for Q3 2023, worth a combined $980K — down 68% from $3.04M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of ORGS and 2 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 2 added.
The largest buyer was Geode Capital Management, adding an estimated $29.1K. The largest seller was Redmond Asset Management, exiting entirely with an estimated $806K sold.
- 20 institutional investors held Orgenesis Inc. Common Stock (ORGS) as of Q3 2023, down from 22 in Q2 2023.
- Funds reported $980K of Orgenesis Inc. Common Stock stock for Q3 2023, down 68% quarter-over-quarter.
- 2 funds opened new Orgenesis Inc. Common Stock positions in Q3 2023 and 4 closed out, a net change of -2 holders.
- The largest Orgenesis Inc. Common Stock buyer in Q3 2023 was Geode Capital Management, an estimated $29.1K added.
- The largest Orgenesis Inc. Common Stock seller in Q3 2023 was Redmond Asset Management, an estimated $806K sold.
Based on aggregated 13F filings for Q3 2023.